These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

684 related items for PubMed ID: 21892216

  • 1. [Thromboembolic prophylaxis 2011: is warfarin on the wane?].
    Di Pasquale G, Riva L.
    G Ital Cardiol (Rome); 2011 Sep; 12(9):556-65. PubMed ID: 21892216
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparative efficacy and safety of new oral anticoagulants in patients with atrial fibrillation.
    Schneeweiss S, Gagne JJ, Patrick AR, Choudhry NK, Avorn J.
    Circ Cardiovasc Qual Outcomes; 2012 Jul 01; 5(4):480-6. PubMed ID: 22787066
    [Abstract] [Full Text] [Related]

  • 4. Overview of the new oral anticoagulants: opportunities and challenges.
    Yeh CH, Hogg K, Weitz JI.
    Arterioscler Thromb Vasc Biol; 2015 May 01; 35(5):1056-65. PubMed ID: 25792448
    [Abstract] [Full Text] [Related]

  • 5. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
    Mantha S, Ansell J.
    Thromb Haemost; 2012 Sep 01; 108(3):476-84. PubMed ID: 22740145
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of the phase III clinical trial designs of novel oral anticoagulants versus warfarin for the treatment of nonvalvular atrial fibrillation: implications for clinical practice.
    Gonzalez-Quesada CJ, Giugliano RP.
    Am J Cardiovasc Drugs; 2014 Apr 01; 14(2):111-27. PubMed ID: 24504768
    [Abstract] [Full Text] [Related]

  • 9. Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation.
    Lip GY, Larsen TB, Skjøth F, Rasmussen LH.
    J Am Coll Cardiol; 2012 Aug 21; 60(8):738-46. PubMed ID: 22575324
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Novel anticoagulants vs warfarin for stroke prevention in atrial fibrillation.
    Turagam MK, Velagapudi P, Bongu NR, Kocheril AG.
    Cardiovasc Hematol Disord Drug Targets; 2014 Aug 21; 14(1):79-86. PubMed ID: 25088126
    [Abstract] [Full Text] [Related]

  • 12. Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients: Danish nationwide descriptive data 2011-2013.
    Olesen JB, Sørensen R, Hansen ML, Lamberts M, Weeke P, Mikkelsen AP, Køber L, Gislason GH, Torp-Pedersen C, Fosbøl EL.
    Europace; 2015 Feb 21; 17(2):187-93. PubMed ID: 25236181
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. New oral anticoagulants for the treatment of venous thromboembolism.
    Agnelli G, Becattini C, Franco L.
    Best Pract Res Clin Haematol; 2013 Jun 21; 26(2):151-61. PubMed ID: 23953903
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Novel oral anticoagulants in secondary prevention of stroke.
    Diener HC, Easton JD, Hankey GJ, Hart RG.
    Best Pract Res Clin Haematol; 2013 Jun 21; 26(2):131-9. PubMed ID: 23953901
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Use of novel oral anticoagulants for patients with atrial fibrillation: systematic review and clinical implications.
    Albert NM.
    Heart Lung; 2014 Jun 21; 43(1):48-59. PubMed ID: 24373340
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.